{"organizations": [], "uuid": "13c46f3473763acb4c78c931f2d4daa1a191e427", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/23/business-wire-applied-dna-schedules-fiscal-2018-second-quarter-financial-results-conference-call-for-thursday-may-3-2018-at-430-pm-et.html", "country": "US", "domain_rank": 767, "title": "Applied DNA Schedules Fiscal 2018 Second Quarter Financial Results Conference Call for Thursday, May 3, 2018 at 4:30 PM ET", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-23T13:30:00.000+03:00", "replies_count": 0, "uuid": "13c46f3473763acb4c78c931f2d4daa1a191e427"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/23/business-wire-applied-dna-schedules-fiscal-2018-second-quarter-financial-results-conference-call-for-thursday-may-3-2018-at-430-pm-et.html", "ord_in_thread": 0, "title": "Applied DNA Schedules Fiscal 2018 Second Quarter Financial Results Conference Call for Thursday, May 3, 2018 at 4:30 PM ET", "locations": [], "entities": {"persons": [], "locations": [{"name": "n.y.", "sentiment": "none"}, {"name": "stony brook", "sentiment": "none"}], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to release financial results for its fiscal 2018 second quarter ended March 31, 2018 after market close on Thursday, May 3, 2018. In conjunction with the release, the Company has scheduled a conference call at 4:30 p.m. Eastern Time that will also be broadcast live over the Internet.\nWhat:\nApplied DNA’s Fiscal 2018 Second Quarter Financial Results Conference Call When:\nThursday, May 3, 2018, at 4:30 p.m. Eastern Time Where:\nVia phone by dialing +1 844-887-9402 or +1 412-317-6798 and ask for the Applied DNA call; via webcast .\nA telephonic replay of the conference call will be available for one day and may be accessed by calling +1 877-344-7529 or +1 412-317-0088 with the passcode 10119469. The webcast will be archived in the Investors section of the company’s website .\nAbout Applied DNA Sciences\nApplied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics, personalized medicine and therapeutics.\nApplied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based \"CertainT®\" platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.\nSigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopiable, security and authentication solutions, targeted a wide range of industries, including but not limited to, pharmaceuticals and nutraceuticals, textiles and defense materials , BackTrac® and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. Our products provide a forensic chain of evidence in large commercial ecosystems\nVisit adnas.com for more information. Follow us on Twitter and LinkedIn . Join our mailing list.\nForward Looking Statements\nThe statements made by Applied DNA in this press release may be \"forward-looking\" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe Applied DNA's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to our lack of significant revenues, limited financial resources, limited market acceptance, history of net losses, market competition, risk of not obtaining regulatory approval and various other factors detailed from time to time in Applied DNA's SEC reports and filings, including our Annual Report on Form 10-K filed on December 28, 2017 and our subsequent quarterly report on Form 10-Q filed on February 8, 2018, which are available at www.sec.gov . Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.\nView source version on businesswire.com : https://www.businesswire.com/news/home/20180423005442/en/\nInvestor:\nLHA Investor Relations\nSanjay M. Hurry, 212-838-3777\nshurry@lhai.com\nWeb: www.adnas.com | twitter: @APDN\nSource: Applied DNA Sciences, Inc.", "external_links": ["http://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fservices.choruscall.com%2Flinks%2Fapdn180503.html&esheet=51792523&newsitemid=20180423005442&lan=en-US&anchor=webcast&index=2&md5=8a0406b32f439fce1754841521acccdb", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.adnas.com&esheet=51792523&newsitemid=20180423005442&lan=en-US&anchor=Applied+DNA+Sciences%2C+Inc.&index=1&md5=f20ef8e74c2a79df7cb1b35e23114c32", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.sec.gov%2F&esheet=51792523&newsitemid=20180423005442&lan=en-US&anchor=www.sec.gov&index=10&md5=d19fd8ca1011703bda1616364b555b58", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.adnas.com%2F&esheet=51792523&lan=en-US&anchor=www.adnas.com&index=11&md5=f18af578d0279767449c94b419afedf1", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.adnas.com%2F&esheet=51792523&newsitemid=20180423005442&lan=en-US&anchor=adnas.com&index=6&md5=e09fc0908045b1dc64f10b949dc9bb5f", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fadnas.com&esheet=51792523&newsitemid=20180423005442&lan=en-US&anchor=website&index=5&md5=91750850f01cc7921b456c1e849c0595", "http://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fvisitor.r20.constantcontact.com%2Fd.jsp%3Fllr%3Dk7qff9dab%26p%3Doi%26m%3D1103610692490%26sit%3Dkzt8grjfb%26f%3De51aaef6-2212-4239-9a18-0070222974fa&esheet=51792523&newsitemid=20180423005442&lan=en-US&anchor=mailing+list.&index=9&md5=9ccaa4d69a4369163abd6c1fce6b6e4c", "https://www.businesswire.com/news/home/20180423005442/en/", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.twitter.com%2Fapdn&esheet=51792523&newsitemid=20180423005442&lan=en-US&anchor=Twitter&index=7&md5=019670ed9de9e891f97c1a10ebca1790", "http://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fservices.choruscall.com%2Flinks%2Fapdn180503.html&esheet=51792523&newsitemid=20180423005442&lan=en-US&anchor=webcast&index=3&md5=1457e2d7b075e94e823b3cae6ce81525", "http://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F73050&esheet=51792523&newsitemid=20180423005442&lan=en-US&anchor=LinkedIn&index=8&md5=62aafed3924fb90a4b96b7188ccbdbe2", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fadnas.com%2Fmolecular-based-security%2Finvestors%2F&esheet=51792523&newsitemid=20180423005442&lan=en-US&anchor=Investors+section&index=4&md5=a20dd4a7743cba5b6718330d8d17998c"], "published": "2018-04-23T13:30:00.000+03:00", "crawled": "2018-04-23T14:40:32.115+03:00", "highlightTitle": ""}